Filing Flows › Twist Bioscience (TWST) › NGS applications revenue
Twist Bioscience (TWST) NGS applications revenue by quarter
Twist Bioscience's NGS applications revenue was $61.8M in Q3 FY26 (third quarter fiscal 2026), +8% from Q2 FY26. Over the last 7 quarters it ranged from $45.5M (Q4 FY24) to $61.8M (Q3 FY26).
| Quarter | NGS applications revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $61.8M | +8% | +12% |
| Q2 FY26 | $57.4M | +9% | +12% |
| Q1 FY26 | $52.6M | -0.7% | — |
| Q4 FY25 | $53.0M | -4% | +16% |
| Q3 FY25 | $55.3M | +8% | — |
| Q2 FY25 | $51.1M | +12% | — |
| Q4 FY24 | $45.5M | — | — |
Q3 FY26 at a glance
Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Twist Bioscience's NGS applications revenue?
Twist Bioscience's NGS applications revenue was $61.8M in Q3 FY26 (third quarter fiscal 2026), +8% from Q2 FY26.
How has Twist Bioscience's NGS applications revenue changed?
Over the last 7 quarters it ranged from $45.5M (Q4 FY24) to $61.8M (Q3 FY26).